ENOXACIN COMPARED WITH CEFOPERAZONE FOR THE TREATMENT OF EXPERIMENTAL ENTEROBACTER-AEROGENES ENDOCARDITIS

被引:8
作者
BOSCIA, JA
KOBASA, WD
KAYE, D
机构
关键词
D O I
10.1128/AAC.27.5.708
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:708 / 711
页数:4
相关论文
共 13 条
[1]  
CARRIZOSA J, 1976, J LAB CLIN MED, V88, P132
[2]   INVITRO ACTIVITY OF CI-919 (AT-2266), AN ORAL ANTI-PSEUDONOMAL COMPOUND [J].
CHARTRAND, SA ;
SCRIBNER, RK ;
WEBER, AH ;
WELCH, DF ;
MARKS, MI .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :658-663
[3]   INVITRO ACTIVITY OF ENOXACIN, A QUINOLONE CARBOXYLIC-ACID, COMPARED WITH THOSE OF NORFLOXACIN, NEW BETA-LACTAMS, AMINOGLYCOSIDES, AND TRIMETHOPRIM [J].
CHIN, NX ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :754-763
[4]  
CRAIG WA, 1980, CLIN THER, V3, P46
[5]   CHEMOTHERAPY OF EXPERIMENTAL STREPTOCOCCAL ENDOCARDITIS .1. COMPARISON OF COMMONLY RECOMMENDED PROPHYLACTIC REGIMENS [J].
DURACK, DT ;
PETERSDORF, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (03) :592-598
[6]  
HUANG PTR, 1983, J LIQ CHROMATOGR, V6, P743
[7]   AZTREONAM, CEFOPERAZONE, AND GENTAMICIN IN THE TREATMENT OF EXPERIMENTAL ENTEROBACTER-AEROGENES ENDOCARDITIS IN RABBITS [J].
KOBASA, WD ;
KAYE, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (03) :321-324
[8]  
LEVISON ME, 1973, J INFECTIOUS DISEA S, V128, P354
[9]   INVITRO ANTI-BACTERIAL PROPERTIES OF AT-2266, A NEW PYRIDONECARBOXYLIC ACID [J].
NAKAMURA, S ;
MINAMI, A ;
KATAE, H ;
INOUE, S ;
YAMAGISHI, J ;
TAKASE, Y ;
SHIMIZU, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :641-648
[10]   PHARMACOKINETICS OF AT-2266 ADMINISTERED ORALLY TO MICE, RATS, DOGS, AND MONKEYS [J].
NAKAMURA, S ;
KUROBE, N ;
KASHIMOTO, S ;
OHUE, T ;
TAKASE, Y ;
SHIMIZU, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (01) :54-60